Identification of novel neuraminidase inhibitors through e-pharmacophore based virtual screening Online publication date: Fri, 06-Nov-2020
by Rohini Kanagavelu; Shanthi Veerappapillai
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 13, No. 4, 2020
Abstract: The surface protein of influenza virus, neuraminidase (NA), is believed to play a critical role in the release of new viral particle and thus spreads infection. Hence it has been considered as a possible drug target for influenza A virus infection. Despite the number of available drugs for influenza infection, the emergence of novel mutants has embellished more resistance to potent NA inhibitor. Therefore, in the present study an attempt has been made to discover potent inhibitors from ASINEX library of 467802 molecules through e-pharmacophore based virtual screening strategy. The results from our analysis along with available experimental evidences comprehend that BAS04358434 could be used as a promising candidate for NA inhibition. Moreover, the hit compound showed potent inhibitory activity against all the mutant structures considered in our analysis. Overall, we speculate that the outcomes of this research are of substantial prominence in the rational designing of novel NA inhibitors.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook